Generated by AI
BioNexus Gene Lab Corp. is a biotechnology and specialty chemicals company based in Kuala Lumpur, Malaysia. The company operates through business segments that include industrial chemical trading and genomic screening services. Through its subsidiaries, it supplies chemical raw materials used in industrial, medical, appliance, automotive, mechanical, and electronic manufacturing across Southeast Asia. BioNexus Gene Lab Corp. also develops blood-based diagnostic services that apply functional genomics and RNA analysis to support early disease detection and personalized health management. Its business model combines distribution of specialty materials with laboratory-focused healthcare solutions, positioning the company at the intersection of industrial supply chains and precision diagnostics. This mix gives BioNexus Gene Lab Corp. a role in both regional manufacturing markets and emerging molecular testing services.
WebsiteMenara UOA Bangsar
Kuala Lumpur, 59000
Malaysia
The latest articles about BGLC.
Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcareKUALA LUMPUR, Malaysia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("Company" or "BGLC") today announced plans to build AI applications for Malaysian healthcare, following the signing of a definitive agreement with Ruanyun Edai Technology Inc. (Nasdaq: RYET) on October 5, 2026 for an exclusive Malaysian healthcare licence to RYET's CogniAI artificial intell
Summary of Jun 10's posts. Generated by AI.
Summary of Sep 12's posts. Generated by AI.
Summary of Oct 20's posts. Generated by AI.
Investors talking about BGLC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.